Brand name prescribing status for Tacrolimus products updated on dm+d
Following representation from PSNC, the NHS Business Services Authority (NHSBSA) has added the ‘Caution – AMP level prescribing advised’ marker to oral Tacrolimus products on the Dictionary of medicines and devices (dm+d). This is in line with the MHRA guidance that oral Tacrolimus products should be prescribed and dispensed by brand name only, to minimise [...]
The post Brand name prescribing status for Tacrolimus products updated on dm+d appeared first on PSNC Website.
Recent Comments